![]() 967,907,473 visitors served. |
|
![]() Dictionary/ thesaurus | ![]() Medical dictionary | ![]() Legal dictionary | ![]() Financial dictionary | ![]() Acronyms | ![]() Idioms | ![]() Encyclopedia | ![]() Wikipedia encyclopedia | ? |
Lennox-Gastaut syndrome |
Also found in: Acronyms, Wikipedia | 0.06 sec. |
|
|
? Mentioned in | ? References in periodicals archive | |
|---|---|---|
| Headquarters: London, Managing Director: Paul Hooper) received a marketing authorization approval for the anti-epileptic agent Inovelon(R) (rufinamide) indicated as adjunctive therapy in Lennox-Gastaut Syndrome (LGS) from the European Commission (EC). announced positive results from its recent study to evaluate the safety and efficacy of clobazam in patients with Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy. Headquarters: London, Managing Director: Paul Hooper) received a positive opinion that recommends a marketing approval of the anti-epileptic agent Inovelon(R) (rufinamide) for adjunctive therapy in Lennox-Gastaut Syndrome (LGS) from the Committee for Medicinal Products for Human Use (CHMP), the scientific body of the European Medicines Evaluation Agency (EMEA). |
| Free Tools: |
For surfers:
Browser extension |
Word of the Day |
Help
For webmasters: Free content NEW! | Linking | Lookup box | Double-click lookup | Partner with us |
|
|---|